Sign in
4

Changes in Ownership

Evommune, Inc. Filed Acc 0002092017-26-000003

Options or other derivatives

  • Chief Scientific Officer acquired 69,315 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Jeegar Pravinkumar Chief Scientific Officer 2026-04-16 Grant or award · Employee Stock Option (Right to Buy) +69,315 69,315 D
Loading xslF345X06/primarydocument.xml…